Evercore ISI Reiterates Buy Rating for Welltower Inc. (WELL)
Evercore ISI reaffirms its buy stance on Welltower Inc. with a $236 price target, a 3.98% upside from the current price.
Key Points
- Evercore ISI Group reiterated its buy rating on Welltower Inc. (WELL) with a price target of $236.
- Evercore ISI Group's $236 price target implies 3.98% upside from Welltower Inc.'s ($WELL) current $226.97 share price.
- Welltower Inc. shares traded near $226.97 on Wednesday, with a market cap of about $160.2 billion.
- Analyst ratings remain strong with multiple firms maintaining buy ratings and price targets above $230.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Evercore ISI Group has reiterated its buy rating on Welltower Inc. (NYSE: WELL), setting a price target of $236. The reaffirmation was made by analyst Steve Sakwa on July 1, 2026. Shares of Welltower traded near $226.97 on Wednesday.
Evercore ISI Group vs. the S&P 500
Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.
Welltower Inc. Stock Down 4.7%
Shares of NYSE:WELL traded around $226.97 on Wednesday. Welltower Inc., with a market capitalization of approximately $160.2 billion, has a P/E ratio of 109.6 and a forward P/E of 67.6. The stock has a 52-week low of $148.97 and a high of $230.07. Its 50-day moving average is $212.29, and the 200-day moving average is $196.35. Welltower maintains a beta of 0.78, indicating lower volatility compared to the market.
$WELL price target
Past daily closes and this analyst's 12-month price target. Not investment advice.
Recent Earnings
Welltower reported revenue of about $11.77 billion, showing a growth of 38.3%. The company's net margin stands at 11.96%, with a return on equity of 3.67%. Earnings per share were $2.07. Investors can look forward to the next earnings report scheduled for July 27, 2026.
Dividend
Welltower offers an annual dividend rate of $2.96, resulting in a yield of 1.3%. The dividend payout ratio is 139.61%, reflecting a significant return to shareholders.
Insider Buying and Selling at Welltower Inc.
CEO Shankh Mitra sold 3,852 shares on June 26, 2026, and bought 17 shares at an average price of $173.32 on May 31, 2026. Dennis Lopez purchased 63 shares at $216.01 on May 21, 2026. Kenneth Bacon was involved in buying 2,627 shares on May 1, 2026.
Analysts Set New Price Targets
On July 1, 2026, Evercore ISI Group maintained its buy rating with a $236 target. Previously, on June 18, 2026, Scotiabank also maintained a buy rating with a $232 target. Raymond James reinstated its buy rating with a $226 target on June 17, 2026. Overall, the consensus recommendation remains a buy, with a mean price target of $235.48 based on 21 analyst opinions.
About Welltower Inc.
Welltower Inc. is a leading real estate investment trust (REIT) focusing on healthcare facilities. Based in Toledo, Ohio, the company operates over 2,500 senior living and wellness communities across the U.S., U.K., and Canada. Under the leadership of CEO Shankh S. Mitra, Welltower's portfolio is strategically located in attractive markets, offering vibrant housing solutions for seniors. The company employs around 712 people and aims to deliver long-term growth through disciplined capital allocation and innovative partnerships.
Bottom Line
Welltower Inc. continues to attract positive attention from analysts, with Evercore ISI's reaffirmation of a buy rating highlighting strong market confidence. Shares remain near their 52-week high, reflecting robust interest in the healthcare REIT sector. As a reminder, analyst ratings and targets are forward-looking and subject to change.
Get Welltower Inc. alerts
New 13F filings, insider trades, and analyst moves on $WELL, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.